Allworth Financial LP Collegium Pharmaceutical, Inc Transaction History
Allworth Financial LP
- $20.2 Billion
- Q2 2025
A detailed history of Allworth Financial LP transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Allworth Financial LP holds 4,351 shares of COLL stock, worth $149,152. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,351
Previous 58
7401.72%
Holding current value
$149,152
Previous $1,000
12700.0%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding COLL
# of Institutions
241Shares Held
36.4MCall Options Held
52.5KPut Options Held
200-
Black Rock Inc. New York, NY5.79MShares$199 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY3.16MShares$108 Million2.15% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.64MShares$90.5 Million1.49% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.25MShares$77.1 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA1.58MShares$54.3 Million0.01% of portfolio
About COLLEGIUM PHARMACEUTICAL, INC
- Ticker COLL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 34,126,200
- Market Cap $1.17B
- Description
- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...